Skip to main content

Secondary navigation:

Carroll School of Management

Dr. Marijn Dekkers

Chairman, Bayer AG

“Innovation: Who Needs It?”

Innovation is paramount not just to the future of companies, but to developed societies, countries, and continents, Bayer AG Chairman Dr. Marijn Dekkers told the Chief Executives’ Club of Boston September 19. Robert Yates, president of EMD Millipore, introduced Dekkers. VIDEO »


“Innovation ... [is] our core competitive weapon. We are, just like our competitors, big ... We have good employees—everybody has good employees. We have access to capital—pretty much everybody has access to capital. We’re all global. In the end, the real differentiating factor for companies like ours is our ability to innovate.”

“We are again at the verge of a tremendous breakthrough opportunity in innovation in pharmaceutical research ... [we] better understand at a cellular level what is happening, and what is driving certain disease patterns at a biochemical level.”

“There is tremendous pressure all over the world ... to bring down the prices for prescription drugs … The danger of pushing prices of prescription drugs down, down, and down is that at some point the business model to invest in these drugs—to develop them … will lose its attractiveness. In the end, the profits that we make on the current drugs really source and fund the [research and development] of the drugs in the future.”


Dow Jones MarketWatch: “Bayer CEO: Price pressure may hurt drug pipeline” ARTICLE »

Reuters: “Bayer CEO decries pressure to lower drug prices” ARTICLE » (via Dow Jones): “Bayer CEO warns price pressure could hurt drug pipelines” ARTICLE »

Boston Globe: “Executives say health cost push threatens innovation” ARTICLE »

Boston Business Journal: “Bayer CEO Marijn Dekkers says he has no plans to expand in Boston area” ARTICLE » “Bayer’s Marijn Dekkers warns Boston College Chief Executives’ Club audience that push to cut health care costs threatens innovation” ARTICLE »

Boston Herald: “Bayer CEO says innovation is key ‘competitive weapon’” ARTICLE »


Event Photos
Marijn Dekkers, Chairman of Bayer AG, addresses the Chief Executives' Club of Boston.
Seated at the Speakers Table (clockwise, from bottom left): John Fernandez, President, Massachusetts Eye and Ear Infirmary; Robert Rivers, President, Eastern Bank; Robert Yates, EMD Millipore; Marijn Dekkers, Chairman, Bayer AG; James Taiclet, Chairman, American Tower; Eric Beyer, President, Tufts Medical Center; Linda Zecher, President, Houghton Mifflin Harcourt; Marc Casper, President, Thermo Fisher Scientific; Patrick Purcell, President, Herald Media; Eric Rosengren, President, Federal Reserve Bank of Boston; Laura Sen, President, BJ's Wholesale Club.
Another "who's who" is gathered!
Members of the media gather around Dr. Dekkers following his remarks.